Clinical Trial Update: A Randomised, Double Blind, Placebo and Active Controlled, Double Dummy,Parallel Group Study to Determine the Safety and Efficacy of Oxycodone/Naloxone Prolonged Release Tablets in Subjects With Moderate to Severe, Chronic Nonmalignant Pain [Phase 3]

View source ↗

Summary

Phase 3 randomized trial assessing safety and efficacy of oxycodone/naloxone prolonged release tablets in adults with moderate to severe chronic nonmalignant pa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonmalignant Pain

Drugs mentioned

• Oxycodone/naloxone prolonged release (oxycodone/naloxone)

Snippet

Sponsor: Mundipharma Research GmbH & Co KG | Conditions: Subjects With Moderate to Severe, Chronic Nonmalignant Pain | Phase 3 | Status: COMPLETED